Despite extensive data reported in the literature [29], in our study, none of the analyzed biomarkers in the inflammation pathways, insulin-IGF axis, or sex hormones played a role in mediating the effect of BMI on breast cancer risk. The gene discussed is INS; the disease is breast carcinoma.